2007Chinese Journal of Cardiovascular MedicineRequires access

Relationship between lipoprotein(a) [LP(a)] and coronary heart disease in Kazakhstan patients

Kuang Zheng-yu

Open publisher page 1 citations

Abstract

Objective To evaluate the relationship between lipoprotein(a) [LP(a)] level and coronary heart disease (CHD) in Kazakhstan patients. Methods We measured plasma LP(a) levels in 40 patients with CHD (at least one vessel narrowing≥50% by angiography) and 40 healthy patients as control. Results LP(a) level in CHD group was significantly higher than that of control group[(338.7±179.6)mg/L vs. (219.8±126.8)mg/L, P0.05]. There was a positive correlation between LP(a) level and lesion severity in CHD patients(r=0.487,P0.05). Conclusions Kazakhstan CHD patients have a higher LP(a) levels.

About this research paper

What this paper is about

Objective To evaluate the relationship between lipoprotein(a) [LP(a)] level and coronary heart disease (CHD) in Kazakhstan patients. Methods We measured plasma LP(a) levels in 40 patients with CHD (at least one vessel narrowing≥50% by angiography) and 40 healthy patients as control. Results LP(a) level in CHD group was significantly higher than that of control group[(338.7±179.6)mg/L vs. (219.8±126.8)mg/L, P0.05]. There was a positive correlation between LP(a) level and lesion severity in CHD patients(r=0.487,P0.05). Conclusions Kazakhstan CHD patients have a higher LP(a) levels.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the relationship between lipoprotein(a) [LP(a)] level and coronary heart disease (CHD) in Kazakhstan patients. Methods We measured plasma LP(a) levels in 40 patients with CHD (at least one vessel narrowing≥50% by angiography) and 40 healthy patients as control. Results LP(a) level in CHD group was significantly higher than that of control group[(338.7±179.6)mg/L vs. (219.8±126.8)mg/L, P0.05]. There was a positive correlation between LP(a) level and lesion severity in CHD patients(r=0.487,P0.05). Conclusions Kazakhstan CHD patients have a higher LP(a) levels.

Key concepts: Medicine, Lipoprotein(a), Internal medicine, Coronary heart disease, Coronary angiography, Cardiology, Lipoprotein, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between lipoprotein(a) [LP(a)] and coronary heart disease in Kazakhstan patients — Research Paper | ScholarLens